[Direct pharmacological proof that beta-adrenergic receptors involved in the insulin secretion are of the beta-2 type].
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose; D004285:Dogs; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007801:Langerhans Cells / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology*; D011863:Radioimmunoassay; D011955:Receptors, Drug / Q000187:drug effects*; D013566:Sympathomimetics / Q000494:pharmacology*
D000318:Adrenergic beta-Agonists; D001786:Blood Glucose; D007328:Insulin; D011955:Receptors, Drug; D013566:Sympathomimetics; D011433:Propranolol
Preuve pharmacologique directe que les récepteurs beta-adrénergiques impliqués dans l'insulino-sécrétion sont de type beta-2.